Today, a Director at CryoPort Inc (Other OTC: CYRX), Richard J. Berman, sold shares of CYRX for $23.82K.
Following Richard J. Berman’s last CYRX Sell transaction on August 22, 2017, the stock climbed by 5.2%.
See today’s analyst top recommended stocks >>
Based on CryoPort Inc’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $4.02 million and GAAP net loss of $2.68 million. In comparison, last year the company earned revenue of $2.71 million and had a GAAP net loss of $1.79 million. Currently, CryoPort Inc has an average volume of 822.3K. The Company has a Price to Book ratio of 15.5703.
The insider sentiment on CryoPort Inc has been positive according to 11 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Richard J. Berman’s trades have generated a -90.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Lake Forest, CA.
